222 related articles for article (PubMed ID: 34709389)
1. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.
Getz KD; Szymczak JE; Li Y; Madding R; Huang YV; Aftandilian C; Arnold SD; Bona KO; Caywood E; Collier AB; Gramatges MM; Henry M; Lotterman C; Maloney K; Mian A; Mody R; Morgan E; Raetz EA; Rubnitz J; Verma A; Winick N; Wilkes JJ; Yu JC; Fisher BT; Aplenc R
JAMA Netw Open; 2021 Oct; 4(10):e2128385. PubMed ID: 34709389
[TBL] [Abstract][Full Text] [Related]
2. A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia.
Getz KD; Miller TP; Seif AE; Li Y; Huang YS; Bagatell R; Fisher BT; Aplenc R
Cancer Med; 2015 Sep; 4(9):1356-64. PubMed ID: 26105201
[TBL] [Abstract][Full Text] [Related]
3. Child and family perceptions of satisfaction with neutropenia management in pediatric acute myeloid leukemia.
Szymczak JE; Getz KD; Madding R; Shuster S; Aftandilian C; Arnold SD; Collier AB; Gramatges MM; Henry M; Hijiya N; Mian A; Raetz E; Fisher BT; Aplenc R
Pediatr Blood Cancer; 2023 Aug; 70(8):e30420. PubMed ID: 37194639
[TBL] [Abstract][Full Text] [Related]
4. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
[TBL] [Abstract][Full Text] [Related]
5. Outpatient consolidation chemotherapy in pediatric acute myeloid leukemia: a retrospective analysis.
Bakhshi S; Singh P; Swaroop C
Hematology; 2009 Oct; 14(5):255-60. PubMed ID: 19843379
[TBL] [Abstract][Full Text] [Related]
6. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
Rivas-Ruiz R; Villasis-Keever M; Miranda-Novales G; Castelán-Martínez OD; Rivas-Contreras S
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009031. PubMed ID: 30887505
[TBL] [Abstract][Full Text] [Related]
7. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
8. Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.
Weycker D; Barron R; Kartashov A; Legg J; Lyman GH
J Oncol Pharm Pract; 2014 Jun; 20(3):190-8. PubMed ID: 23824496
[TBL] [Abstract][Full Text] [Related]
9. Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia.
Felsenstein S; Orgel E; Rushing T; Fu C; Hoffman JA
Pediatr Infect Dis J; 2015 Apr; 34(4):e78-84. PubMed ID: 25764103
[TBL] [Abstract][Full Text] [Related]
10. Outpatient supportive care for pediatric acute myeloid leukemia: a single institution's experience.
Potashner R; Weinblatt ME; Glasser CL
Pediatr Hematol Oncol; 2021 Nov; 38(8):722-730. PubMed ID: 33792501
[TBL] [Abstract][Full Text] [Related]
11. Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia.
Li Y; Newton JG; Getz KD; Huang YS; Seif AE; Fisher BT; Aplenc R; Winestone LE
Pediatr Blood Cancer; 2019 Apr; 66(4):e27583. PubMed ID: 30585685
[TBL] [Abstract][Full Text] [Related]
12. Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia.
Elgarten CW; Otto WR; Shenton L; Stein MT; Horowitz J; Aftandilian C; Arnold SD; Bona KO; Caywood E; Collier AB; Gramatges MM; Henry M; Lotterman C; Maloney K; Modi AJ; Mian A; Mody R; Morgan E; Raetz EA; Verma A; Winick N; Wilkes JJ; Yu JC; Aplenc R; Fisher BT; Getz KD
Infect Control Hosp Epidemiol; 2023 Feb; 44(2):222-229. PubMed ID: 35465865
[TBL] [Abstract][Full Text] [Related]
13. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
Sung L; Feldman BM; Schwamborn G; Paczesny D; Cochrane A; Greenberg ML; Maloney AM; Hendershot EI; Naqvi A; Barrera M; Llewellyn-Thomas HA
J Clin Oncol; 2004 Oct; 22(19):3922-9. PubMed ID: 15459214
[TBL] [Abstract][Full Text] [Related]
14. Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemia.
Szymczak JE; Getz KD; Madding R; Fisher B; Raetz E; Hijiya N; Gramatges MM; Henry M; Mian A; Arnold SD; Aftandilian C; Collier AB; Aplenc R
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286570
[TBL] [Abstract][Full Text] [Related]
15. Costs associated with febrile neutropenia in the US.
Michels SL; Barron RL; Reynolds MW; Smoyer Tomic K; Yu J; Lyman GH
Pharmacoeconomics; 2012 Sep; 30(9):809-23. PubMed ID: 22804805
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial.
El-Jawahri A; LeBlanc TW; Kavanaugh A; Webb JA; Jackson VA; Campbell TC; O'Connor N; Luger SM; Gafford E; Gustin J; Bhatnagar B; Walker AR; Fathi AT; Brunner AM; Hobbs GS; Nicholson S; Davis D; Addis H; Vaughn D; Horick N; Greer JA; Temel JS
JAMA Oncol; 2021 Feb; 7(2):238-245. PubMed ID: 33331857
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes of pediatrics acute myeloid leukemia (AML) and associated factors in the country's tertiary referral hospital, Ethiopia.
Mamo W; Moges A; Yesuf SA; Mohamedsaid A; Arega G
BMC Cancer; 2024 May; 24(1):640. PubMed ID: 38789952
[TBL] [Abstract][Full Text] [Related]
18. Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States.
Maude SL; Fitzgerald JC; Fisher BT; Li Y; Huang YS; Torp K; Seif AE; Kavcic M; Walker DM; Leckerman KH; Kilbaugh TJ; Rheingold SR; Sung L; Zaoutis TE; Berg RA; Nadkarni VM; Thomas NJ; Aplenc R
Pediatr Crit Care Med; 2014 Feb; 15(2):112-20. PubMed ID: 24366507
[TBL] [Abstract][Full Text] [Related]
19. Using Social Media to Uncover Treatment Experiences and Decisions in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis.
Booth A; Bell T; Halhol S; Pan S; Welch V; Merinopoulou E; Lambrelli D; Cox A
J Med Internet Res; 2019 Nov; 21(11):e14285. PubMed ID: 31755871
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
